How much revenue does the pulmonary stents market generate?

In 2027 the market for pulmonary stents is valued at USD 261.67 million.

What is the forecasted size of the pulmonary stents industry?

Pulmonary Stents Market size was assessed at USD 251.8 million in 2026 and is poised to grow at a 4.66% CAGR between 2027 and 2036, attaining USD 397.07 million by 2036.

How is the rising burden of COPD and lung cancer influencing demand for pulmonary stents?

Increasing COPD and lung cancer cases are raising incidence of airway obstruction requiring rapid intervention. Pulmonary stents are used in minimally invasive bronchoscopy procedures to restore airway patency, providing symptom relief and supporting patients unsuitable for surgical treatment.

How are innovations in stent design and minimally invasive procedures shaping pulmonary stent adoption?

Advancements such as biodegradable, drug-eluting, and 3D-printed stents are improving placement precision and reducing complications like migration and restenosis. Combined with expanding minimally invasive pulmonary procedures, this is increasing adoption within interventional pulmonology workflows.

Why do Balloon-expandable Stents dominate the pulmonary stents market?

Balloon-expandable Stents captured a 56.07% share in 2026, supported by precise deployment, controlled placement, and strong physician familiarity in pulmonary procedures where procedural accuracy is essential.

Why are Laryngeal Stents the fastest-growing type in the pulmonary stents market?

Laryngeal Stents are expanding quickly as demand increases for specialized upper-airway interventions requiring targeted support in anatomically complex laryngeal conditions where conventional stents are less suitable.

What supports North America's leadership in the pulmonary stents market?

North America accounted for 46.31% of the market in 2026, supported by advanced interventional care infrastructure, specialized hospitals, and consistent use of stent-based pulmonary procedures.

Why is Asia Pacific becoming the fastest-growing pulmonary stents market?

Asia Pacific is projected to grow at a 5.7% CAGR as healthcare systems expand interventional capabilities, improve access to specialized respiratory care, and increase minimally invasive pulmonary procedures.

What are the prominent companies operating in the pulmonary stents landscape?

Prominent companies in the pulmonary stents market include Boston Scientific Corporation (United States), Cook Medical LLC (United States), ENDO-FLEX GmbH (Germany), Efer Endoscopy (France), E. Benson Hood Laboratories, Inc. (United States), Merit Medical Systems, Inc. (United States), Micro-Tech Endoscopy USA Inc. (United States), Taewoong Medical Co., Ltd. (South Korea), Olympus Corporation (Japan), Medtronic plc (Ireland).